Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)
Clinical trial NCT04644120 · COMPLETED
Trial details
- NCT number
- NCT04644120
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-10
- Primary completion
- 2021-08-24
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.